BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
 | Browse: 414 | Download: 571
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 8049
Country
Received
2013-12-12 17:30
Peer-Review Started
2013-12-13 08:57
To Make the First Decision
2014-02-27 09:30
Return for Revision
2014-03-06 09:52
Revised
2014-04-24 09:47
Second Decision
2014-06-03 16:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-03 16:33
Articles in Press
2014-06-03 16:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-08-01 15:04
Publish the Manuscript Online
2014-09-04 09:25
ISSN 2150-5349 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pharmacology & Pharmacy
Manuscript Type Review
Article Title Pharmacological therapy of feed intolerance in the critically ills
Manuscript Source Invited Manuscript
All Author List Nam Q Nguyen
Funding Agency and Grant Number
Corresponding Author Nam Q Nguyen, Associate Professor, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, North Terrace, Adelaide, 5000 South Australia, Australia. quoc.nguyen@health.sa.gov.au
Key Words Adverse effects; Critical illness; Enteral feeding; Feed intolerance; Prokinetic therapy
Core Tip Feed intolerance during critical illness must be promptly recognized and treated due to the associated morbidity and mortality. The current first line treatment for feed intolerance is prokinetic therapy with erythromycin and metoclopramide (alone or in combination), which are highly effective and free of significant adverse effects. Although diarrhoea occurs commonly after combination prokinetic therapy, it is not associated with Clostridium difficile colitis and settled shortly after stopping the treatment. The use of prokinetic therapy over a long period or for prophylactic purpose, therefore, must be avoided and the indication for ongoing use of the drug(s) should be frequently reviewed.
Publish Date 2014-09-04 09:25
Citation Nguyen NQ. Pharmacological therapy of feed intolerance in the critically ills. World J Gastrointest Pharmacol Ther 2014; 5(3): 148-155
URL http://www.wjgnet.com/2150-5349/full/v5/i3/148.htm
DOI http://dx.doi.org/10.4292/wjgpt.v5.i3.148
Full Article (PDF) WJGPT-5-148.pdf
Full Article (Word) WJGPT-5-148.doc
Manuscript File 8049-Review.doc
Answering Reviewers 8049-Answering reviewers.pdf
Copyright License Agreement 8049-Copyright assignment.pdf
Peer-review Report 8049-Peer review(s).pdf
Scientific Misconduct Check 8049-CrossCheck.jpg
Scientific Editor Work List 8049-Scientific editor work list.pdf